Department of Emergency Medicine, Prisma Health, University of South Carolina School of Medicine Greenville, 701 Grove Rd, Greenville, SC 29605, USA.
Department of Emergency Medicine, Yale University, 464 Congress Ave, New Haven, CT 06510, USA.
Am J Emerg Med. 2021 Aug;46:63-69. doi: 10.1016/j.ajem.2021.02.058. Epub 2021 Mar 1.
Although timely administration of antibiotics has an established benefit in serious bacterial infection, the majority of studies evaluating antibiotic delay focus only on the first dose. Recent evidence suggests that delays in redosing may also be associated with worse clinical outcome. In light of the increasing burden of boarding in Emergency Departments (ED) and subsequent need to redose antibiotic in the ED, we examined the association between delayed second antibiotic dose administration and mortality among patients admitted from the ED with a broad array of infections and characterized risk factors associated with delayed second dose administration.
We performed a retrospective cohort study of patients admitted through five EDs in a single healthcare system from 1/2018 through 12/2018. Our study included all patients, aged 18 years or older, who received two intravenous antibiotic doses within a 30-h period, with the first dose administered in the ED. Patients with end stage renal disease, cirrhosis and extremes of weight were excluded due to a lack of consensus on antibiotic dosing intervals for these populations. Delay was defined as administration of the second dose at a time-point greater than 125% of the recommended interval. The primary outcome was in-hospital mortality.
A total of 5605 second antibiotic doses, occurring during 4904 visits, met study criteria. Delayed administration of the second dose occurred during 21.1% of visits. After adjustment for patient characteristics, delayed second dose administration was associated with increased odds of in-hospital mortality (OR 1.50, 95%CI 1.05-2.13). Regarding risk factors for delay, every one-hour increase in allowable compliance time was associated with a 18% decrease in odds of delay (OR 0.82 95%CI 0.75-0.88). Other risk factors for delay included ED boarding more than 4 h (OR 1.47, 95%CI 1.27-1.71) or a high acuity presentation as defined by emergency severity index (ESI) (OR 1.54, 95%CI 1.30-1.81 for ESI 1-2 versus 3-5).
Delays in second antibiotic dose administration were frequent in the ED and early hospital course, and were associated with increased odds of in-hospital mortality. Several risk factors associated with delays in second dose administration, including ED boarding, were identified.
虽然及时给予抗生素在严重细菌感染中有明确的益处,但大多数评估抗生素延迟的研究仅关注第一剂。最近的证据表明,再次给药的延迟也可能与更差的临床结局相关。鉴于急诊科(ED)的住院人数不断增加,以及随后需要在 ED 再次给予抗生素,我们研究了在 ED 就诊的广泛感染患者中,第二剂抗生素延迟给药与死亡率之间的关联,并确定了与第二剂延迟给药相关的危险因素。
我们对 2018 年 1 月至 2018 年 12 月期间,在一个单一医疗系统的 5 家 ED 住院的患者进行了回顾性队列研究。我们的研究包括所有年龄在 18 岁或以上,在 30 小时内接受两剂静脉用抗生素,第一剂在 ED 给予的患者。由于缺乏对这些人群抗生素给药间隔的共识,我们排除了终末期肾病、肝硬化和极端体重的患者。延迟定义为给药时间点大于推荐间隔的 125%。主要结局为住院死亡率。
共有 5605 剂第二剂抗生素,发生在 4904 次就诊中,符合研究标准。在 21.1%的就诊中,第二剂的给药延迟。在调整了患者特征后,第二剂延迟给药与住院死亡率增加相关(OR 1.50,95%CI 1.05-2.13)。关于延迟的危险因素,允许的依从时间每增加 1 小时,延迟的可能性就降低 18%(OR 0.82,95%CI 0.75-0.88)。延迟的其他危险因素包括 ED 住院时间超过 4 小时(OR 1.47,95%CI 1.27-1.71)或紧急严重指数(ESI)定义的高急症(OR 1.54,95%CI 1.30-1.81,ESI 1-2 与 3-5 相比)。
ED 和早期住院过程中,第二剂抗生素给药延迟很常见,与住院死亡率增加相关。确定了与第二剂给药延迟相关的几个危险因素,包括 ED 住院时间和 ESI。